Pat Phelan-backed weight loss company Viv to be wound down
Business sustained ‘mounting losses’ amid competition from drugs like Ozempic
Mounjaro
Weight-loss injections: ‘Two years ago I had to use a mobility scooter, this year I am hiking’
High costs are a common worry among users of Ozempic, Mounjaro and other weight-loss drugs, who report varying levels of success
Ireland’s drugs budget rising every year in ‘unsustainable’ trajectory
Two more cases being examined in Portiuncula hospital reveiew, Oireachtas committee hears
Serena Williams’ endorsement of weight loss medication is a game changer
Williams is not the first sportsperson to promote GLP-1 weight loss medication but she is the most high profile and easily the most significant
The history of weight loss is littered with supposed quick fixes
GLP-1 agonists such as Ozempic and Wegovy have a lot of promise
Black market weight-loss drugs ‘not worth the risk’, warn pharmacists
Union advises people to only purchase drugs from registered pharmacies
Eli Lilly obesity pill disappoints in trial, sending shares down 14%
Weight loss comes in at lower end of expectations and triggers stock boost for rival Novo Nordisk
‘A slow-moving car crash’: Novo Nordisk’s troubles keep mounting
Novo Nordisk has now lost two-thirds of its value in little over a year
In Ozempic’s home town they fear two things: a new set of tariffs, and a company in Kinsale
Pharmaceutical giants in Europe brace themselves for a tariffs fight that is likely still to come
Lilly’s weight loss pill is a ‘landmark moment’ in the obesity fight
Prof Donal O’Shea hails breakthrough and says it may play key role in reshaping treatments
Weight loss drug Wegovy to cost around €220 a month as supplies go on market in Ireland
Weight loss drug is not yet approved for reimbursement under Drug Payment Scheme or for medical card patients
Eli Lilly unveils $27bn US investment as corporate America seeks to woo Trump
CEO Dave Ricks credits Donald Trump with inspiring its push for US-based manufacturing
Insurers will not cover obesity drugs that will cost users €2,500-plus a year
Patients looking to access Eli Lilly’s Mounjaro from next week will have to pay privately
Electricity network upgrades likely to see user bills rise
Seen & heard: Developers summoned; Xerotech on the brink; Glencore eyes Pallas Green sale; CRH invests in 3D; Mounjaro arrives; and O’Hara brewery talks
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
The GlossOpens in new window
Read the digital edition of The Gloss magazine now
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices